Not applicableStudy completedNCT02995057What this trial is testingSafety Demonstration of Microneedle InsertionWho this might be right forAllergic Reaction to Nickel University of British Columbia 15
Not applicableStudy completedNCT06687512What this trial is testingA Clinical Study to Assess the Safety and Effectiveness of Test Products in Mild to Moderate Atopic Dermatitis (AD) Patients.Who this might be right forAtopic Dermatitis NovoBliss Research Pvt Ltd 44
Not applicableStudy completedNCT03262428What this trial is testingCollaborative Self-Management Support in Chronic Conditions - Qualitative StudyWho this might be right forAsthmaBreast CancerStroke Hospices Civils de Lyon 109
Large-scale testing (Phase 3)Study completedNCT02896101What this trial is testingStudy of Generic Pimecrolimus Cream, 1% in the Treatment of Mild to Moderate Atopic DermatitisWho this might be right forAtopic Dermatitis Glenmark Pharmaceuticals Ltd. India 755
Early research (Phase 1)Study completedNCT04548869What this trial is testingA Single Dose Study of the Safety, Pharmacokinetics and Pharmacodynamics of CDX-0159 in Patients With Cold Contact Urticaria, Symptomatic Dermographism, or Cholinergic UrticariaWho this might be right forCold UrticariaCold Contact UrticariaSymptomatic Dermographism+2 more Celldex Therapeutics 41
Not applicableStudy completedNCT02098551What this trial is testingSkin Testing With Recombinant Bet v 1 and Hypoallergenic Recombinant Bet v 1 FragmentsWho this might be right forAtopic Dermatitis Stefan Woehrl 30
Large-scale testing (Phase 3)Study completedNCT01264939What this trial is testingA Safety Study of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU) Who Remain Symptomatic Despite Treatment With H1 Antihistamines, H2 Blockers, and/or Leukotriene Receptor AntagonistsWho this might be right forChronic Idiopathic Urticaria Genentech, Inc. 336
Post-approval studies (Phase 4)Study completedNCT02680301What this trial is testingTopical Steroid Formulation and Wet WrapsWho this might be right forDermatitis, Atopic Seton Healthcare Family 40
Testing effectiveness (Phase 2)Ended earlyNCT00927212What this trial is testingTopical Application of AS101 for the Treatment of Atopic DermatitisWho this might be right forAtopic Dermatitis BioMAS Ltd 5
Testing effectiveness (Phase 2)Study completedNCT00076375What this trial is testingPreliminary Study of Safety and Efficacy of Nanocrystalline Silver Cream in Atopic Dermatitis (Eczema)Who this might be right forAtopic DermatitisEczema Nucryst Pharmaceuticals 180
Not applicableStudy completedNCT05049512What this trial is testingLow Dose Multi-Nut Oral Immunotherapy in Pre-schoolers With a Multi-Nut AllergyWho this might be right forAllergy, Nut Murdoch Childrens Research Institute 12
Not applicableStudy completedNCT07046039What this trial is testingThe Impact of Untreated Depression and Anxiety Among Patients With Skin Diseases in Jeddah, Saudi Arabia.Who this might be right forAlopecia AreataAcne VulgarisPsoriasis+4 more King Abdulaziz University 215
Not applicableLooking for participantsNCT06238765What this trial is testingCorEvitas International Adolescent Atopic Dermatitis (AD) Drug Safety and Effectiveness RegistryWho this might be right forAtopic Dermatitis CorEvitas 1,500
Testing effectiveness (Phase 2)Study completedNCT03562377What this trial is testingVaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)Who this might be right forAtopic Dermatitis LEO Pharma 215
Testing effectiveness (Phase 2)Active Not RecruitingNCT07220577What this trial is testingPhase 2a Study to Assess the Efficacy,Safety and Tolerability of GIA632 in Adult Participants With Moderate to Severe Atopic DermatitisWho this might be right forAtopic Dermatitis Novartis Pharmaceuticals 34
Testing effectiveness (Phase 2)Looking for participantsNCT03835767What this trial is testingFood-Specific and Component IgE Threshold Levels That Predict Food Allergy in People With Elevated Total Serum IgE Levels and Atopic DermatitisWho this might be right forMilk and/or Peanut Allergy National Institute of Allergy and Infectious Diseases (NIAID) 200
Testing effectiveness (Phase 2)Ended earlyNCT05999799What this trial is testingA Dose Finding Study to Investigate the Safety and Effectiveness of GSK1070806 in Adult Participants With Moderate to Severe Atopic DermatitisWho this might be right forDermatitis, Atopic GlaxoSmithKline 161
Not applicableStudy completedNCT02626221What this trial is testingA Worldwide Antihistamine-Refractory Chronic Urticaria Patient Evaluation in Latin America and Canada (AWARE-LACan)Who this might be right forChronic Urticaria Novartis Pharmaceuticals 497
Testing effectiveness (Phase 2)Active Not RecruitingNCT05120830What this trial is testingNTLA-2002 in Adults With Hereditary Angioedema (HAE)Who this might be right forHereditary Angioedema Intellia Therapeutics 37
Not applicableStudy completedNCT05904509What this trial is testingInsulin Resistance in Atopic Dermatitis PatientsWho this might be right forAtopic Dermatitis Bezmialem Vakif University 32